For what? It's a shell. There are shells out there with a higher SP. Should the company sell their Pambula/Moruya assets, and begin again? Maybe they should return capital to holders.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025